Form 4 for BA Boeing
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001225208-25-002183 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-21 | 2025-02-19 | BA | Raymond David Christopher | EVP, Pres, CEO, BGS | A - Grant | $0.00 | +6,340 | 46.5K | +16% | $0 |
| D | 2025-02-21 | 2025-02-19 | BA | Raymond David Christopher | EVP, Pres, CEO, BGS | A - Grant | $0.00 | +18.0K | 18.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | A | A | 6,340 | $0.00 | 46,502.45 | D | — | — | (F1) Represents restricted stock units of which 2,092 units will vest on February 19, 2026, 2,092 units will vest on February 19, 2027, and 2,156 units will vest on February 22, 2028; units settle in shares of the Company's common stock on a one-for-one basis. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-02-19 | A | A | 17,980 | $0.00 | 17,980 | D | $221.44 · 2028-02-19 to 2035-02-19 | 17,980 Common Stock | (F4) The exercise price is equal to 120% of the average of the high and low trading prices on the date of grant. (F5) The option becomes vested and exercisable in full on February 19, 2028, which is the third anniversary of the date of grant. |